Deficiency of YTHDF1 functionally prevents NSCLC cell proliferation and tumor formation through inhibiting the translational efficiency of cyclin-dependent kinase 2 (CDK2), cyclin-dependent kinase 4 (CDK4), and cyclin D1 (CCND1). Here, CDK2 is linked to non-small cell lung carcinoma.